findmyKOL
Clinical trialNCT04737265CompletedPhase 1/PHASE2Interventional

Pilot Study of an NTproBNP Guided Strategy of Cardioprotection

SponsorAbramson Cancer Center at Penn MedicineEnrollment108Breast CancerCardiomyopathiesCardiotoxicityHeart FailureLymphomaToxicity Due to Chemotherapy
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope

    Duarte, California, United States

  • Abramson Cancer Center at University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Chester County Hospital

    West Chester, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Mar 2021
Primary completion
5 Feb 2025
Completion
5 Feb 2025
Last update posted
15 Jun 2026
Registered enrollment
108
Registry id
NCT04737265

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.